HOME >> MEDICINE >> NEWS
Researchers identify leukemia-linked pathway targeted by a new kinase inhibitor

BAR HARBOR, MAINE--Three years ago, using the first of a new class of drugs known as "small molecule kinase inhibitors," medicine slammed shut a door used by cancer. Researchers at The Jackson Laboratory just found another door that kinase inhibitors may close to cancer.

The gene BCR-ABL1 causes two types of leukemia: chronic myelogeneous leukemia (CML) and B-cell acute lymphoblastic leukemia (B-ALL). In both cancers, enzymes that should regulate the growth and development of white blood cells go awry, resulting in uncontrolled growth of the cells. The Swiss-based pharmaceutical company Novartis developed Gleevec, the first kinase inhibitor used to fight cancer by blocking the errant enzyme. It proved effective against chronic phase of CML, but not the advanced phase or against B-ALL. In some patients, it seems CML can develop a resistance to Gleevec.

In the May 2004 issue of Nature Genetics, a research team headed by Shaoguang Li, M.D., Ph.D., of The Jackson Laboratory, announces success with another kinase inhibitor that blocks a different path used by cancer. Studying mice, the researchers discovered that the BCR-ABL1 gene activates three additional enzymes that lead to B-ALL leukemia. One of these enzymes may also be involved when CML patients no longer respond to Gleevec.

"Because of drug resistance, it becomes increasingly difficult to stop progression of and cure this disease by targeting at only one place in a multi-molecule-involved signaling pathway used by cancer," says Dr. Li. "So we needed to find a combined drug therapy targeting simultaneously more than one places in the pathway."

First, the team developed the first efficient and accurate mouse models of both forms of BCR-ABL1-induced leukemia. Next, they discovered that three of the Src kinase class of enzymes are required for B-ALL but not for CML, suggesting that different therapeutic strategies should be used for treating these two diseases although they are induced
'"/>

Contact: Joyce Peterson
joyce@jax.org
207-288-6058
Jackson Laboratory
18-Apr-2004


Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
8. Researchers offer emergency workers a lifeline
9. Researchers discover genetic variant that may explain why women develop M.S. more than men
10. Researchers map the sexual network of an entire high school
11. Researchers hope monkeys can provide new insights into depression

Post Your Comments:
(Date:4/27/2015)... PREVENT Life Safety, America’s premier provider of life ... addition of an account manager in Houston. In order ... customer base, Curtis Rice, an experienced sales professional, has ... Curtis has been added to the team to generate ... area and beyond. , Curtis brings with ...
(Date:4/27/2015)... 27, 2015 Health conscious businesses in ... first-of-its-kind bakery right on their doorstep, which will offer ... on restrictive and low-carbohydrate diets. This nut-based ... starch free, and will use only natural sweeteners like ... 2015, strives to provide specialty food that is currently ...
(Date:4/27/2015)... April 27, 2015 Jvion, the Atlanta-based ... Atlanta Pacesetter and recognized as one of the top ... award, which is presented by the Atlanta Business Chronicle, ... accelerate Atlanta’s status as an economic capital and employment ... success is spurred by the growing need to improve ...
(Date:4/26/2015)... York (PRWEB) April 26, 2015 ... 21, 2015 in the U.S. District Court, Northern ... lawsuits ( http://www.testosteronelawsuithub.com/ ) have been consolidated ... to court documents, matters addressed included the intention ... of claims involving their products on preemption grounds, ...
(Date:4/26/2015)... has released a new blog post explaining how to find ... to find low cost auto insurance is by comparing quotes. ... in a simple and convenient way. It is no longer ... prices. All the details are now freely available to anyone ... possible to compare online car insurance quotes on a single ...
Breaking Medicine News(10 mins):Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2Health News:Nourish Bakery Serves Up Healthy Eating in Huntsville, Alabama 2Health News:Jvion Named to Top 40 Atlanta 2015 Pacesetters 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 2Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 3Health News:Court Overseeing Federal Testosterone Treatment Lawsuits Convenes April Case Management Conference 4Health News:Finding Low Cost Auto Insurance - An Online Guide Provides Tips 2
(Date:4/27/2015)... 27, 2015 TWi Pharmaceuticals, Inc. ("TWi") ... Settlement Agreement with Takeda Pharmaceutical Company Limited, Takeda ... Pharmaceuticals America, Inc. (individually and collectively, "Takeda") to ... to TWi,s generic dexlansoprazole delayed release capsules for ... dosage strengths. An Abbreviated New Drug Application for TWi,s ...
(Date:4/25/2015)...  With the introduction of Elekta,s new Leksell Gamma ... now available for more patients with a wider variety ... radiosurgery system for the brain, integrates advanced motion management, ... of Gamma Knife radiosurgery. Elekta unveiled Leksell Gamma Knife ... in Barcelona . "This ...
(Date:4/24/2015)... , April 24, 2015  Perrigo Company plc ("Perrigo" ... rejection of the unsolicited offer from Mylan NV ("Mylan") ... outstanding shares of Perrigo for $60.00 per share in ... Perrigo share (the "Offer").  The Board ... share significantly undervalued the Company and its future growth ...
Breaking Medicine Technology:TWi Announces Settlement with Takeda on Dexilant(R) Litigation 2New Leksell Gamma Knife to benefit more patients with brain disease 2New Leksell Gamma Knife to benefit more patients with brain disease 3Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4
Cached News: